Tumor suppressor role of phospholipase Ce in Ras-triggered cancers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages 4239-4244

  Martins, Marta ^a   McCarthy, Afshan ^b   Baxendale, Rhona ^b   Guichard, Sabrina ^b   Magno, Lorenza ^c   Kessaris, Nicoletta ^c   El Bahrawy, Mona ^d   Yu, Philipp ^e   Katan, Matilda ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HISTONE DEACETYLASE; K RAS PROTEIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON; PROTEIN P53; RAS PROTEIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, TRANSGENIC; NEOPLASMS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PROTEIN KINASE C; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84896530480     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311500111     Document Type: Article

References (31)

1. Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D (2011) RAS oncogenes: Weaving a tumorigenic web. Nat Rev Cancer 11(11):761-774.
2. González-García A, et al. (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7(3):219-226. (Pubitemid 40568681)
3. Gupta S, et al. (2007) Binding of ras to phosphoinositide 3-kinase p110alpha is required for Ras-driven tumorigenesis in mice. Cell 129(5):957-968. (Pubitemid 46802703)
4. Blasco RB, et al. (2011) c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 19(5):652-663.
5. Zimmermann G, et al. (2013) Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling. Nature 497(7451):638-642.
6. Kumar MS, et al. (2012) The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 149(3):642-655.
7. Peschard P, et al. (2012) Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis. Curr Biol 22(21):2063-2068.
8. Puyol M, et al. (2010) A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma. Cancer Cell 18(1):63-73.
9. Barbie DA, et al. (2009) Systematic RNA interference reveals that oncogenic KRASdriven cancers require TBK1. Nature 462(7269):108-112.
10. O'Hagan RC, Heyer J (2011) KRAS mouse models: Modeling cancer harboring KRAS mutations. Genes Cancer 2(3):335-343.
11. Pérez-Mancera PA, Guerra C, Barbacid M, Tuveson DA (2012) What we have learned about pancreatic cancer from mouse models. Gastroenterology 142(5):1079-1092.
12. Tommasi S, et al. (2005) Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65(1):92-98. (Pubitemid 40070799)
13. Bunney TD, Katan M (2006) Phospholipase C epsilon: Linking second messengers and small GTPases. Trends Cell Biol 16(12):640-648. (Pubitemid 44809889)
14. Bunney TD, Katan M (2011) PLC regulation: Emerging pictures for molecular mechanisms. Trends Biochem Sci 36(2):88-96.
15. Bunney TD, et al. (2006) Structural and mechanistic insights into ras association domains of phospholipase C epsilon. Mol Cell 21(4):495-507. (Pubitemid 43228005)
16. Smrcka AV, Brown JH, Holz GG (2012) Role of phospholipase Ce in physiological phosphoinositide signaling networks. Cell Signal 24(6):1333-1343.
17. Bunney TD, Katan M (2010) Phosphoinositide signalling in cancer: Beyond PI3K and PTEN. Nat Rev Cancer 10(5):342-352.
18. Ikuta S, Edamatsu H, Li M, Hu L, Kataoka T (2008) Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester. Cancer Res 68(1):64-72. (Pubitemid 351380106)
19. Li M, Edamatsu H, Kitazawa R, Kitazawa S, Kataoka T (2009) Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis. Carcinogenesis 30(8):1424-1432.
20. Oka M, et al. (2010) Enhancement of ultraviolet B-induced skin tumor development in phospholipase Ce-knockout mice is associated with decreased cell death. Carcinogenesis 31(10):1897-1902.
21. Sorli SC, Bunney TD, Sugden PH, Paterson HF, Katan M (2005) Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene 24(1):90-100. (Pubitemid 40143868)
22. Wang X, et al. (2012) Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol 29(2):1051-1058.
23. Danielsen SA, et al. (2011) Phospholipase C isozymes are deregulated in colorectal cancer - Insights gained from gene set enrichment analysis of the transcriptome. PLoS ONE 6(9):e24419.
24. Bai Y, et al. (2004) Crucial role of phospholipase Cepsilon in chemical carcinogeninduced skin tumor development. Cancer Res 64(24):8808-8810. (Pubitemid 39665481)
25. Finch JS, Albino HE, Bowden GT (1996) Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/ RFLP. Carcinogenesis 17(12):2551-2557. (Pubitemid 27037608)
26. Hennings H, et al. (1993) FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14(11):2353-2358. (Pubitemid 23335193)
27. Fujiwara K, Wie B, Elliott R, Nagase H (2010) New outbred colony derived from Mus musculus castaneus to identify skin tumor susceptibility loci. Mol Carcinog 49(7): 653-661.
28. Angel JM, Caballero M, DiGiovanni J (2003) Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice. Cancer Res 63(11):2747-2751. (Pubitemid 36667144)
29. Gazin C, Wajapeyee N, Gobeil S, Virbasius CM, Green MR (2007) An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449(7165):1073-1077. (Pubitemid 350014604)
30. Chida K, et al. (2003) Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res 63(10):2404-2408. (Pubitemid 36605176)
31. Wang X, et al. (2008) Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology 55(88):2039-2044.